Rivaroxaban is an imported drug that is a new oral anticoagulant with high bioavailability, long time window of action, safe and effective, and does not require monitoring of coagulation compared to traditional warfarin. Because it is a new type of drug, the cost can be very high during the patent period. At present, with the drug reform and the reform of China’s medical industry, the price of rivaroxaban is gradually decreasing, from the original more than 100 yuan a piece to more than 20 yuan a piece now, and it can also take the medical insurance, so the price is moderate for the people, and the efficacy is also very good. If you have the financial conditions, it is recommended to choose rivaroxaban for treatment.